|
|
|
| Webinar: Streamlining Cell Culture Media Manufacturing | Join us August 15th with Thermo Fisher Scientific as we address effective ways to accelerate cell culture media manufacturing, including rapid, small-scale non-CGMP media prototyping and outsourcing options to ensure an uninterrupted supply of your cell culture media raw materials. We will share ways to improve quality, simplify technology transfer of proprietary media formulations, and mitigate logistical challenges associated with custom media scale-up processes. Click here to learn more. |
|
|
FOCUS ON UPSTREAM MANUFACTURING |
|
|
|
By Pooja Sharma, Global Market Insights | Cell culture media are ubiquitous in just about every bioprocess system, and advanced modalities are putting specialty media in the spotlight. |
|
|
|
|
|
| Rev-Up AAV Genome Production In Upstream Manufacturing | Application Note | By Becky Reese, Jennifer Swanson, Austin Storck and Laura Juckem, Mirus Bio | By increasing recombinant AAV titers, this AAV enhancer can help reduce upstream manufacturing costs and lower the cost per therapeutic dose. |
|
|
|
|
|
|
| Ready To Amplify Plasmid (pDNA) In Bacteria? | Article | By Valentina Haag, INFORS HT | Explore how to use and amplify pDNA from the development of recombinant proteins and viral vectors to advanced bio-therapeutics such as mRNA vaccines. |
|
|
|
|
|
|
| AI and machine learning are the buzzwords of the decade, often accompanied by lofty promises — but what do they really mean for biopharma? How can these technologies be adopted to improve biomanufacturing processes, testing, and quality? Join Bioprocess Online Live for an exploration into the practical applications of AI/ML in biomanufacturing, its barriers to adoption, and how regulators can help standardize use across the industry. Registration is free thanks to the support of Atum Bio. |
|
|
UPSTREAM MANUFACTURING SOLUTIONS |
|
|
|
|
|
|
|
|
| Webinar: Accelerating mAb Process Development in the Growing Therapeutics Market | Join us on August 20th as Thermo Fisher Scientific scientists explore the latest strategies and advancements in early stage mAb up- and downstream process development. They will share valuable insight on stable CHO cell line development for mAb production, media and feed screening strategies to meet clone specific nutritional needs, and techniques to enhance purification process development by high-throughput screening. Click here to learn more. |
|
|
| Connect With Bioprocess Online: |
|
|
|
